Related Experiment Video
Updated: May 20, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain
Mie A Rizig1, Andrew McQuillin, Aylwin Ng
1Molecular Psychiatry Laboratory, University College London, London, UK.
Abstract:
Clozapine has markedly superior clinical properties compared to other antipsychotic drugs but the side effects of agranulocytosis, weight gain and diabetes limit its use. The reason why clozapine is more effective is not well understood. We studied messenger RNA (mRNA) gene expression in the mouse brain to identify pathways changed by clozapine compared to those changed by haloperidol so that we could identify which changes were specific to clozapine. Data interpretation was performed using an over-representation analysis (ORA) of gene ontology (GO), pathways and gene-by-gene differences. Clozapine significantly changed gene expression in pathways related to neuronal growth and differentiation to a greater extent than haloperidol; including the microtubule-associated protein kinase (MAPK) signalling and GO terms related to axonogenesis and neuroblast proliferation. Several genes implicated genetically or functionally in schizophrenia such as frizzled homolog 3 (FZD3), U2AF homology motif kinase 1 (UHMK1), pericentriolar material 1 (PCM1) and brain-derived neurotrophic factor (BDNF) were changed by clozapine but not by haloperidol. Furthermore, when compared to untreated controls clozapine specifically regulated transcripts related to the glutamate system, microtubule function, presynaptic proteins and pathways associated with synaptic transmission such as clathrin cage assembly. Compared to untreated controls haloperidol modulated expression of neurotoxic and apoptotic responses such as NF-kappa B and caspase pathways, whilst clozapine did not. Pathways involving lipid and carbohydrate metabolism and appetite regulation were also more affected by clozapine than by haloperidol.
Insights
Clozapine uniquely promotes neuronal growth pathways and regulates genes linked to schizophrenia, unlike haloperidol. This suggests clozapine
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Clozapine exhibits superior efficacy over other antipsychotics but is limited by side effects.
- The molecular mechanisms underlying clozapine's enhanced effectiveness remain poorly understood.
Purpose of the Study:
- To elucidate clozapine's unique molecular actions by comparing its gene expression profile in the mouse brain with that of haloperidol.
- To identify pathways and genes specifically modulated by clozapine, potentially explaining its superior clinical profile.
Main Methods:
- Messenger RNA (mRNA) gene expression analysis in mouse brain tissue.
- Over-representation analysis (ORA) of gene ontology (GO) terms and pathways.
- Comparative analysis of gene expression changes induced by clozapine versus haloperidol.
Main Results:
- Clozapine significantly enhanced gene expression in pathways related to neuronal growth, differentiation, axonogenesis, and neuroblast proliferation more than haloperidol.
- Genes implicated in schizophrenia (e.g., FZD3, UHMK1, PCM1, BDNF) were differentially regulated by clozapine.
- Clozapine specifically modulated glutamate system transcripts, microtubule function, presynaptic proteins, and synaptic transmission pathways, while haloperidol induced neurotoxic and apoptotic responses.
Conclusions:
- Clozapine's superior clinical efficacy may stem from its distinct ability to promote neurotrophic and neurodevelopmental pathways.
- Clozapine's gene expression profile suggests a neuroprotective and plasticity-enhancing mechanism, contrasting with haloperidol's pro-apoptotic effects.
- Understanding these molecular differences provides insight into optimizing antipsychotic treatment strategies.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Antipsychotic Drugs: Typical and Atypical Agents
Psychological and Sociocultural Causes of Schizophrenia
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

